Skip to content

News

Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing

Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing together with 5 other start-ups in the sector organized by Telefonica Open Future. Last year, Biosfer Teslab was selected to participate in the Tarragona Open Future where it was awarded with the second place. Open… Read More »Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing

Biosfer Teslab invitada en el primer Futurecamp Open Future

Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine… Read More »Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

Metabolòmica al the Liver meeting

Barça Innovation Hub: Metabolomics at the forefront of elite sport

The Barça Innovation Hub (BIHUB) was created four years ago by the FC Barcelona to develop technological advances applied to sport and improve performance at the highest level. This large Barça Laboratory aims to exploit the synergy between sport and technology in order to reach the levels of demand required by the club. To work at… Read More »Barça Innovation Hub: Metabolomics at the forefront of elite sport

Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and… Read More »Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

Liposcale Breast cancer

Liposcale in Circulation

Frequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small studies have shown that supplementing the diet with nuts has a considerable effect on reducing dietary cholesterol in the short term, there is little information… Read More »Liposcale in Circulation

Liposcale in Circulation

Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve… Read More »Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

malaltia cardiovascular ateromatosa

Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the IISPV, the URV and the spin-off Biosfer Teslab, SL. The call granted has been “Replegar-se per crèixer: l’impacte de les pandèmies en un món sense… Read More »Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

Covid-19

Early molecular signature of Parkinson and dementia years before the diseases appear

NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the… Read More »Early molecular signature of Parkinson and dementia years before the diseases appear